Found: 111
Select item for more details and to access through your institution.
Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 4, p. 885, doi. 10.1093/jac/dkq546
- By:
- Publication type:
- Article
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteers.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 1, p. 180, doi. 10.1093/jac/dkq411
- By:
- Publication type:
- Article
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 6, p. 1233, doi. 10.1093/jac/dkp102
- By:
- Publication type:
- Article
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 6, p. 1344, doi. 10.1093/jac/dkn399
- By:
- Publication type:
- Article
Pharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosing.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 1, p. 161, doi. 10.1093/jac/dkn187
- By:
- Publication type:
- Article
Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 5, p. 908, doi. 10.1093/jac/dki354
- By:
- Publication type:
- Article
The management of HIV-1 protease inhibitor pharmacokinetic interactions.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 1, p. 1, doi. 10.1093/jac/dki184
- By:
- Publication type:
- Article
Boosted saquinavir hard gel formulation exposure in HIV-infected subjects: ritonavir 100?mg once daily versus twice daily.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 4, p. 542, doi. 10.1093/jac/dki043
- By:
- Publication type:
- Article
Pharmacokinetics of saquinavir co-administered with cimetidine.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Sleep Disorders in Human Immunodeficiency Virus: A Substudy of the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) Study.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 1, p. 1, doi. 10.1093/ofid/ofaa561
- By:
- Publication type:
- Article
A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 2, p. N.PAG, doi. 10.1093/ofid/ofz035
- By:
- Publication type:
- Article
Ritonavir: 25 Years' Experience of Concomitant Medication Management. A Narrative Review.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 5, p. 1005, doi. 10.1007/s40121-024-00959-6
- By:
- Publication type:
- Article
Changes in functional connectivity in people with HIV switching antiretroviral therapy.
- Published in:
- Journal of NeuroVirology, 2020, v. 26, n. 5, p. 754, doi. 10.1007/s13365-020-00853-0
- By:
- Publication type:
- Article
Effect of a Modified Saquinavir/Ritonavir Dosing Regimen with Lower Dose Lead-In Phase on QTc Interval, Pharmacokinetics, Antiviral Activity and Safety in Treatment-Naïve HIV-1-Infected Patients.
- Published in:
- Drugs in R&D, 2015, v. 15, n. 1, p. 141, doi. 10.1007/s40268-015-0087-7
- By:
- Publication type:
- Article
Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults.
- Published in:
- AIDS Research & Treatment, 2012, p. 1, doi. 10.1155/2012/105980
- By:
- Publication type:
- Article
Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
- Published in:
- Journal of the International AIDS Society, 2019, v. 22, n. 9, p. N.PAG, doi. 10.1002/jia2.25372
- By:
- Publication type:
- Article
Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19562
- By:
- Publication type:
- Article
Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19827
- By:
- Publication type:
- Article
Should the dose of tenofovir be reduced to 200-250 mg/day, when combined with protease inhibitors?
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19583
- By:
- Publication type:
- Article
Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approach.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19586
- By:
- Publication type:
- Article
Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19747
- By:
- Publication type:
- Article
Results of a Multi-Disciplinary Approach Involving Geriatricians of a Clinic for Older People Living with HIV.
- Published in:
- AIDS Patient Care & STDs, 2023, v. 37, n. 5, p. 213, doi. 10.1089/apc.2023.0011
- By:
- Publication type:
- Article
Effects of the H<sub>2</sub>-Receptor Antagonist Famotidine on the Pharmacokinetics of Atazanavir-Ritonavir With or Without Tenofovir in HIV-Infected Patients.
- Published in:
- AIDS Patient Care & STDs, 2011, v. 25, n. 9, p. 509, doi. 10.1089/apc.2011.0113
- By:
- Publication type:
- Article
Episodic disability questionnaire (EDQ) measurement properties among adults living with HIV in Canada, Ireland, United Kingdom, and United States.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-023-08958-7
- By:
- Publication type:
- Article
Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults.
- Published in:
- Chemotherapy Research & Practice, 2011, p. 1, doi. 10.1155/2011/393976
- By:
- Publication type:
- Article
Prevention of atherosclerosis in patients living with HIV.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Prevention of atherosclerosis in patients living with HIV.
- Published in:
- Vascular Health & Risk Management, 2009, v. 5, p. 287
- By:
- Publication type:
- Article
Correction to: Clinical management of ageing people living with HIV in Europe: the view of the care providers.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Clinical management of ageing people living with HIV in Europe: the view of the care providers.
- Published in:
- Infection, 2020, v. 48, n. 4, p. 497, doi. 10.1007/s15010-020-01406-7
- By:
- Publication type:
- Article
New Approaches to Antiretroviral Drug Delivery: Challenges and Opportunities Associated with the Use of Long-Acting Injectable Agents.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Non-Immunogenicity of Overlapping Gag Peptides Pulsed on Autologous Cells after Vaccination of HIV Infected Individuals.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0074389
- By:
- Publication type:
- Article
A Randomised, Placebo-Controlled, First-In-Human Study of a Novel Clade C Therapeutic Peptide Vaccine Administered <i>Ex Vivo</i> to Autologous White Blood Cells in HIV Infected Individuals.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0073765
- By:
- Publication type:
- Article
Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART.
- Published in:
- Brain Sciences (2076-3425), 2019, v. 9, n. 8, p. 195, doi. 10.3390/brainsci9080195
- By:
- Publication type:
- Article
A case report highlighting drug–drug interactions between 3 life‐saving treatments: Feminizing hormones, antiretrovirals and antituberculosis drugs.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2383, doi. 10.1111/bcp.16064
- By:
- Publication type:
- Article
Anastrozole as a therapeutic option for gynecomastia in a person receiving antiretroviral therapy: Case report.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 1, p. 350, doi. 10.1111/bcp.15951
- By:
- Publication type:
- Article
Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 2078, doi. 10.1111/bcp.14619
- By:
- Publication type:
- Article
Introduction.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, p. 1, doi. 10.1111/j.1365-2125.2008.03131.x
- By:
- Publication type:
- Article
A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, p. 54, doi. 10.1111/j.1365-2125.2008.03136.x
- By:
- Publication type:
- Article
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0253861
- By:
- Publication type:
- Article
Iatrogenic Cushing's syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies.
- Published in:
- Clinical Medicine, 2016, v. 16, n. 5, p. 412, doi. 10.7861/clinmedicine.16-5-412
- By:
- Publication type:
- Article
Strengths and Challenges of Various Models of Geriatric Consultation for Older Adults Living With Human Immunodeficiency Virus.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 6, p. 1101, doi. 10.1093/cid/ciab682
- By:
- Publication type:
- Article
Indirect Human Immunodeficiency Virus Morbidity and Mortality Due to Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 10, p. 1947, doi. 10.1093/cid/ciab128
- By:
- Publication type:
- Article
Pharmacokinetics of Efavirenz 400 mg Once Daily Coadministered With Isoniazid and Rifampicin in Human Immunodeficiency Virus–Infected Individuals.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 3, p. 446, doi. 10.1093/cid/ciy491
- By:
- Publication type:
- Article
Increased Dolutegravir Peak Concentrations in People Living With Human Immunodeficiency Virus Aged 60 and Over, and Analysis of Sleep Quality and Cognition.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 1, p. 87, doi. 10.1093/cid/ciy426
- By:
- Publication type:
- Article
Antiviral Activity, Safety, and Exposure–Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002).
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 3, p. 442, doi. 10.1093/cid/cix239
- By:
- Publication type:
- Article
Pharmacology Lessons From Chemoprophylaxis Studies.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. suppl_1, p. S52, doi. 10.1093/cid/ciu250
- By:
- Publication type:
- Article